🔗 Permalink

Inventor profile of:

Antje Danielczyk

City:

Berlin

Country:

Germany

Published Applications:

Last publication date:

2025-08-14

Top Assignees for applications by Antje Danielczyk

The entities that hold a legal rights for patent applications filed by inventor Danielczyk Antje:

GLYCOTOPE GMBH 8 Berlin, Germany
DAIICHI SANKYO CO., LTD. 4 Tokyo, Japan
Pentixapharm AG 1 Würzburg, Germany

Recent patent applications by Danielczyk Antje

Antje Danielczyk from Berlin, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-08-14

US20250257149A1

Chemistry; metallurgy

ANTI-MUC1 ANTIBODY

#2 | 2025-07-10

US20250223375A1

Chemistry; metallurgy

ANTI-MUC1 ANTIBODY-DRUG CONJUGATE

#3 | 2025-03-06

US20250074999A1

Chemistry; metallurgy

ANTIBODIES AGAINST LYPD3

#4 | 2023-11-23

US20230372520A1

Human necessities

Anti-MUC1 antibody-drug conjugate

#5 | 2023-07-27

US20230235076A1

Chemistry; metallurgy

HUMANIZED ANTIBODIES AGAINST LEWIS Y

#6 | 2023-05-04

US20230139769A1

Human necessities

Anti-MUC1 antibody-drug conjugate

#7 | 2021-07-22

US20210221910A1

Chemistry; metallurgy

Anti-MUC1 antibody

#8 | 2021-06-24

US20210187118A1

Human necessities

ANTI-MUC1 ANTIBODY-DRUG CONJUGATE

#9 | 2021-04-15

US20210107961A1

Chemistry; metallurgy

Fusion Protein Constructs Comprising an Anti-MUC1 Antibody and IL-15

#10 | 2020-04-30

US20200131275A1

Chemistry; metallurgy

MULTISPECIFIC ANTIBODY CONSTRUCTS BINDING TO MUC1 AND CD3

#11 | 2020-03-19

US20200087410A1

Chemistry; metallurgy

HUMANIZED ANTI-CD40 ANTIBODIES

#12 | 2019-11-28

US20190359731A1

Chemistry; metallurgy

USE OF HUMAN CELLS OF MYELOID LEUKAEMIA ORIGIN FOR EXPRESSION OF ANTIBODIES

#13 | 2018-04-05

US20180094279A1

Chemistry; metallurgy

Eukaryotic expression vectors comprising regulatory elements of the globin gene clusters

#14 | 2018-02-01

US20180028680A1

Human necessities

GLYCOOPTIMIZED ANTIBODY DRUG CONJUGATES

#15 | 2016-03-10

US20160068609A1

Chemistry; metallurgy

ANTI-CANCER TREATMENTS WITH ANTI-EGFR ANTIBODIES HAVING A LOW FUCOSYLATION

#16 | 2015-12-24

US20150368363A1

Chemistry; metallurgy

Use of human cells of myeloid leukemia origin for expression of antibodies

#17 | 2015-12-10

US20150353959A1

Chemistry; metallurgy

PEPTIDES FOR ENHANCING PROTEIN EXPRESSION

#18 | 2015-06-18

US20150166664A1

Chemistry; metallurgy

NOVEL THERAPEUTIC TREATMENTS WITH ANTI-HER2 ANTIBODIES HAVING A LOW FUCOSYLATION

#19 | 2013-10-17

US20130273033A1

Chemistry; metallurgy

Humanized EGFR antibodies

#20 | 2013-08-15

US20130209458A1

Chemistry; metallurgy

Fab-glycosylated antibodies

InventorID:

388486 ⎘